Brown Brothers Harriman & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.06M | Buy |
59,318
+8,556
| +17% | +$1.31M | 0.05% | 151 |
|
|
2025
Q4 | $7M | Buy |
50,762
+1,822
| +4% | +$239K | 0.04% | 146 |
|
|
2025
Q3 | $6.28M | Sell |
48,940
-1,237
| -2% | -$151K | 0.04% | 144 |
|
|
2025
Q2 | $6.07M | Sell |
50,177
-11,362
| -18% | -$1.28M | 0.04% | 139 |
|
|
2025
Q1 | $6.86M | Sell |
61,539
-1,506
| -2% | -$160K | 0.05% | 134 |
|
|
2024
Q4 | $6.13M | Buy |
63,045
+10,113
| +19% | +$1.08M | 0.04% | 138 |
|
|
2024
Q3 | $6.09M | Sell |
52,932
-2,988
| -5% | -$339K | 0.04% | 136 |
|
|
2024
Q2 | $5.95M | Buy |
55,920
+7,823
| +16% | +$785K | 0.04% | 132 |
|
|
2024
Q1 | $4.65M | Sell |
48,097
-150
| -0.3% | -$15.4K | 0.04% | 149 |
|
|
2023
Q4 | $4.87M | Sell |
48,247
-13,045
| -21% | -$1.26M | 0.04% | 142 |
|
|
2023
Q3 | $6.24M | Sell |
61,292
-1,346
| -2% | -$137K | 0.06% | 124 |
|
|
2023
Q2 | $6.32M | Sell |
62,638
-1,100
| -2% | -$110K | 0.05% | 115 |
|
|
2023
Q1 | $5.86M | Sell |
63,738
-7,277
| -10% | -$636K | 0.05% | 103 |
|
|
2022
Q4 | $6.44M | Sell |
71,015
-2,578
| -4% | -$217K | 0.06% | 97 |
|
|
2022
Q3 | $5.59M | Sell |
73,593
-10,102
| -12% | -$837K | 0.05% | 100 |
|
|
2022
Q2 | $7.08M | Sell |
83,695
-13,094
| -14% | -$1.15M | 0.06% | 95 |
|
|
2022
Q1 | $8.49M | Sell |
96,789
-27,201
| -22% | -$2.36M | 0.06% | 95 |
|
|
2021
Q4 | $10.8K | Sell |
123,990
-18,014
| -13% | -$1.5M | 0.06% | 89 |
|
|
2021
Q3 | $11.6K | Sell |
142,004
-10,544
| -7% | -$949K | 0.07% | 81 |
|
|
2021
Q2 | $13.9K | Sell |
152,548
-45,346
| -23% | -$4.04M | 0.08% | 75 |
|
|
2021
Q1 | $16.9K | Sell |
197,894
-82,295
| -29% | -$7.39M | 0.11% | 72 |
|
|
2020
Q4 | $26.5M | Sell |
280,189
-61,208
| -18% | -$5.35M | 0.18% | 61 |
|
|
2020
Q3 | $29.7M | Sell |
341,397
-3,613,526
| -91% | -$313M | 0.21% | 59 |
|
|
2020
Q2 | $345M | Sell |
3,954,923
-137,049
| -3% | -$11.8M | 2.6% | 12 |
|
|
2020
Q1 | $337M | Sell |
4,091,972
-295,413
| -7% | -$26.4M | 2.75% | 13 |
|
|
2019
Q4 | $415M | Sell |
4,387,385
-354,912
| -7% | -$31.8M | 2.65% | 12 |
|
|
2019
Q3 | $412M | Sell |
4,742,297
-1,206,226
| -20% | -$108M | 2.75% | 12 |
|
|
2019
Q2 | $543M | Sell |
5,948,523
-910,694
| -13% | -$77.1M | 3.61% | 8 |
|
|
2019
Q1 | $591M | Sell |
6,859,217
-374,313
| -5% | -$30M | 4.07% | 7 |
|
|
2018
Q4 | $556M | Sell |
7,233,530
-1,154,896
| -14% | -$89.9M | 4.21% | 7 |
|
|
2018
Q3 | $648M | Sell |
8,388,426
-599,257
| -7% | -$44.3M | 4.01% | 8 |
|
|
2018
Q2 | $608M | Sell |
8,987,683
-972,108
| -10% | -$67.1M | 3.73% | 8 |
|
|
2018
Q1 | $722M | Sell |
9,959,791
-298,068
| -3% | -$22.7M | 4.16% | 8 |
|
|
2017
Q4 | $772M | Sell |
10,257,859
-981,185
| -9% | -$74M | 4.24% | 8 |
|
|
2017
Q3 | $865M | Sell |
11,239,044
-88,969
| -0.8% | -$6.72M | 4.61% | 6 |
|
|
2017
Q2 | $847M | Sell |
11,328,013
-721,086
| -6% | -$51.1M | 4.59% | 6 |
|
|
2017
Q1 | $802M | Sell |
12,049,099
-194,841
| -2% | -$13M | 4.35% | 6 |
|
|
2016
Q4 | $799M | Buy |
12,243,940
+1,729,617
| +16% | +$112M | 4.37% | 6 |
|
|
2016
Q3 | $744M | Sell |
10,514,323
-299,817
| -3% | -$21.8M | 3.95% | 8 |
|
|
2016
Q2 | $800M | Buy |
10,814,140
+29,263
| +0.3% | +$2.02M | 4.15% | 6 |
|
|
2016
Q1 | $700M | Buy |
10,784,877
+1,021,558
| +10% | +$69.5M | 3.61% | 9 |
|
|
2015
Q4 | $753M | Sell |
9,763,319
-605,989
| -6% | -$48.1M | 3.97% | 8 |
|
|
2015
Q3 | $854M | Sell |
10,369,308
-483,646
| -4% | -$43M | 4.35% | 7 |
|
|
2015
Q2 | $956M | Sell |
10,852,954
-401,743
| -4% | -$36.9M | 4.47% | 5 |
|
|
2015
Q1 | $994M | Sell |
11,254,697
-330,967
| -3% | -$29.4M | 4.5% | 5 |
|
|
2014
Q4 | $962M | Sell |
11,585,664
-1,060,149
| -8% | -$87.9M | 4.05% | 6 |
|
|
2014
Q3 | $1.07B | Sell |
12,645,813
-70,321
| -0.6% | -$5.69M | 4.29% | 6 |
|
|
2014
Q2 | $1.03B | Sell |
12,716,134
-1,107,204
| -8% | -$87.1M | 4.18% | 5 |
|
|
2014
Q1 | $1.05B | Buy |
13,823,338
+55,506
| +0.4% | +$4.04M | 4.5% | 5 |
|
|
2013
Q4 | $992M | Sell |
13,767,832
-969,793
| -7% | -$67.4M | 4.48% | 5 |
|
|
2013
Q3 | $1.01B | Buy |
14,737,625
+212,864
| +1% | +$14.1M | 4.79% | 4 |
|
|
2013
Q2 | $920M | Buy |
+14,524,761
| New | +$945M | 4.36% | 4 |
|
Other funds holding NVS
Brown Brothers Harriman & Co's NVS Position: Q1 2026 in Review
Brown Brothers Harriman & Co increased its Novartis (NVS) stake by 17% in Q1 2026, buying an estimated $1.31M and bringing the position to 59,318 shares worth $9.06M. The position accounts for 0.05% of the portfolio, ranked #151.
Brown Brothers Harriman & Co first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.07B in Q3 2014. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Brown Brothers Harriman & Co held 59,318 shares of Novartis worth $9.06M as of Q1 2026.
- Brown Brothers Harriman & Co bought 8,556 Novartis shares in Q1 2026, an estimated $1.31M.
- Novartis made up 0.05% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #151 holding.
- Brown Brothers Harriman & Co first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Brown Brothers Harriman & Co's Novartis position peaked at $1.07B in Q3 2014.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.